Matisse Capital’s Johnson & Johnson JNJ Stock Holding History

Matisse Capital’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$450K	Sell	1,839 -4	-0.2%	-$932	0.19%	106
2025 Q4	$381K	Buy	1,843 +5	+0.3%	+$989	0.17%	123
2025 Q3	$341K	Buy	1,838 +18	+1%	+$3.08K	0.15%	128
2025 Q2	$278K	Hold	1,820	–	–	0.13%	149
2025 Q1	$302K	Sell	1,820 -45	-2%	-$7.04K	0.16%	139
2024 Q4	$270K	Hold	1,865	–	–	0.14%	146
2024 Q3	$302K	Hold	1,865	–	–	0.15%	148
2024 Q2	$273K	Hold	1,865	–	–	0.13%	162
2024 Q1	$295K	Sell	1,865 -15	-0.8%	-$2.39K	0.14%	157
2023 Q4	$295K	Buy	1,880 +60	+3%	+$9.2K	0.16%	156
2023 Q3	$284K	Hold	1,820	–	–	0.2%	140
2023 Q2	$301K	Hold	1,820	–	–	0.19%	141
2023 Q1	$282K	Hold	1,820	–	–	0.18%	146
2022 Q4	$322K	Buy	+1,820	New	+$314K	0.29%	93
2022 Q3	–	Sell	-1,820	Closed	-$323K	–	105
2022 Q2	$323K	Hold	1,820	–	–	0.31%	94
2022 Q1	$323K	Buy	1,820 +150	+9%	+$25.5K	0.3%	88
2021 Q4	$286K	Hold	1,670	–	–	0.2%	111
2021 Q3	$270K	Hold	1,670	–	–	0.1%	129
2021 Q2	$275K	Hold	1,670	–	–	0.09%	127
2021 Q1	$274K	Hold	1,670	–	–	0.08%	141
2020 Q4	$262K	Hold	1,670	–	–	0.08%	129
2020 Q3	$249K	Hold	1,670	–	–	0.1%	115
2020 Q2	$235K	Hold	1,670	–	–	0.08%	128
2020 Q1	$219K	Hold	1,670	–	–	0.09%	152
2019 Q4	$244K	Hold	1,670	–	–	0.17%	88
2019 Q3	$216K	Sell	1,670 -443	-21%	-$58.4K	0.27%	76
2019 Q2	$294K	Hold	2,113	–	–	0.37%	66
2019 Q1	$295K	Hold	2,113	–	–	0.36%	66
2018 Q4	$273K	Hold	2,113	–	–	0.34%	71
2018 Q3	$292K	Buy	2,113 +161	+8%	+$21.4K	0.26%	92
2018 Q2	$237K	Hold	1,952	–	–	0.19%	104
2018 Q1	$250K	Buy	1,952 +400	+26%	+$54.1K	0.15%	104
2017 Q4	$217K	Buy	1,552 +1	+0.1%	+$139	0.1%	120
2017 Q3	$202K	Buy	1,551 +1	+0.1%	+$133	0.1%	116
2017 Q2	$205K	Buy	+1,550	New	+$198K	0.1%	110
2016 Q4	–	Sell	-2,091	Closed	-$247K	–	104
2016 Q3	$247K	Buy	2,091 +1	+0%	+$121	0.13%	85
2016 Q2	$253K	Buy	2,090 +2	+0.1%	+$227	0.14%	84
2016 Q1	$226K	Sell	2,088 -1,169	-36%	-$121K	0.12%	88
2015 Q4	$335K	Buy	+3,257	New	+$328K	0.17%	76

Other funds holding JNJ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Matisse Capital's JNJ Position: Q1 2026 in Review

Matisse Capital reduced its Johnson & Johnson (JNJ) stake by 0.22% in Q1 2026, selling an estimated $932 and leaving 1,839 shares worth $450K. The position accounts for 0.19% of the portfolio, ranked #106.

Matisse Capital first reported a position in JNJ in Q4 2015 and has held it in 39 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

Matisse Capital held 1,839 shares of Johnson & Johnson worth $450K as of Q1 2026.
Matisse Capital sold 4 Johnson & Johnson shares in Q1 2026, an estimated $932.
Johnson & Johnson made up 0.19% of Matisse Capital's portfolio in Q1 2026, its #106 holding.
Matisse Capital first reported a position in Johnson & Johnson in Q4 2015 and has held it in 39 quarters since.
4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Matisse Capital's 13F filing for Q1 2026, filed 8 May 2026.